Fig. 1From: Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort studySample recruitment diagram from cohort of patients on ART for at least 6 months at JUSH, September, 2012 to July, 2014Back to article page